17-31095310-A-T

Variant summary

Our verdict is Pathogenic. The variant received 24 ACMG points: 24P and 0B. PVS1PS1_ModeratePS3PM2PP5_Very_Strong

The NM_001042492.3(NF1):​c.1A>T​(p.Met1?) variant causes a initiator codon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000722 in 1,385,312 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV002232564: Disruption of the initiator codon has been observed in individuals with neurofibromatosis type 1 (PMID:23668869, 23913538, 31573083).".

Frequency

Genomes: not found (cov: 30)
Exomes 𝑓: 7.2e-7 ( 0 hom. )

Consequence

NF1
NM_001042492.3 initiator_codon

Scores

5
4
7

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:4

Conservation

PhyloP100: 2.60

Publications

1 publications found
Variant links:
Genes affected
NF1 (HGNC:7765): (neurofibromin 1) This gene product appears to function as a negative regulator of the ras signal transduction pathway. Mutations in this gene have been linked to neurofibromatosis type 1, juvenile myelomonocytic leukemia and Watson syndrome. The mRNA for this gene is subject to RNA editing (CGA>UGA->Arg1306Term) resulting in premature translation termination. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. [provided by RefSeq, Jul 2008]
MIR4733HG (HGNC:55332): (MIR4733 host gene)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 24 ACMG points.

PVS1
Start lost variant, next in-frame start position is after 117 pathogenic variants. Next in-frame start position is after 68 codons. Genomic position: 31156124. Lost 0.024 part of the original CDS.
PS1
Another start lost variant in NM_001042492.3 (NF1) was described as [Likely_pathogenic] in ClinVar
PS3
PS3 evidence extracted from ClinVar submissions: SCV002232564: Disruption of the initiator codon has been observed in individuals with neurofibromatosis type 1 (PMID: 23668869, 23913538, 31573083).
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-31095310-A-T is Pathogenic according to our data. Variant chr17-31095310-A-T is described in ClinVar as Pathogenic. ClinVar VariationId is 1455045.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001042492.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NF1
NM_001042492.3
MANE Select
c.1A>Tp.Met1?
initiator_codon
Exon 1 of 58NP_001035957.1P21359-1
NF1
NM_000267.4
c.1A>Tp.Met1?
initiator_codon
Exon 1 of 57NP_000258.1
NF1
NM_001128147.3
c.1A>Tp.Met1?
initiator_codon
Exon 1 of 15NP_001121619.1P21359-5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NF1
ENST00000358273.9
TSL:1 MANE Select
c.1A>Tp.Met1?
initiator_codon
Exon 1 of 58ENSP00000351015.4P21359-1
NF1
ENST00000356175.7
TSL:1
c.1A>Tp.Met1?
initiator_codon
Exon 1 of 57ENSP00000348498.3P21359-2
NF1
ENST00000431387.8
TSL:1
c.1A>Tp.Met1?
initiator_codon
Exon 1 of 15ENSP00000412921.4P21359-5

Frequencies

GnomAD3 genomes
Cov.:
30
GnomAD4 exome
AF:
7.22e-7
AC:
1
AN:
1385312
Hom.:
0
Cov.:
32
AF XY:
0.00000146
AC XY:
1
AN XY:
683444
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31494
American (AMR)
AF:
0.00
AC:
0
AN:
35608
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25122
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35732
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79078
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
38440
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4090
European-Non Finnish (NFE)
AF:
9.28e-7
AC:
1
AN:
1078066
Other (OTH)
AF:
0.00
AC:
0
AN:
57682
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
30

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
2
-
-
Neurofibromatosis, type 1 (2)
1
-
-
Hereditary cancer-predisposing syndrome;CN230736:Cardiovascular phenotype (1)
1
-
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Pathogenic
0.25
D
BayesDel_noAF
Uncertain
0.12
CADD
Uncertain
24
DANN
Benign
0.96
DEOGEN2
Uncertain
0.56
D
Eigen
Benign
0.12
Eigen_PC
Benign
0.090
FATHMM_MKL
Benign
0.55
D
LIST_S2
Uncertain
0.90
D
M_CAP
Pathogenic
1.0
D
MetaRNN
Pathogenic
0.98
D
MetaSVM
Benign
-1.1
T
PhyloP100
2.6
PROVEAN
Benign
-1.6
N
REVEL
Uncertain
0.35
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.65
P
Vest4
0.64
MutPred
1.0
Loss of MoRF binding (P = 0.0789)
MVP
0.83
ClinPred
1.0
D
GERP RS
2.5
PromoterAI
-0.33
Neutral
Varity_R
0.95
gMVP
0.65
Mutation Taster
=0/200
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1060500252; hg19: chr17-29422328; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.